Cardiotoxicity associated with the use of trastuzumab in breast cancer patients. - Wikidata - wikimedia - TriplyDB

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

http://www.wikidata.org/entity/Q37025960

about

Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer.Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments.Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?Imaging and chemotherapy cardiotoxicity: A long-playing story still seeking precision and improved outcomes/management data.Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.

P2860

Q34022527-1EB39046-08B5-410E-95E1-C27194AB71C0 Q35039202-40E7B18E-C45F-4885-8A5F-3326484BCAB5 Q37078963-49A3924E-2484-4FBA-90AE-51B74B4E3731 Q38735433-361B98E8-E4BB-4349-844F-6355EABD1F95 Q38786052-5414267E-A9F9-4A9D-8BD4-F3CBEC0C3C80 Q41704131-700F7DAB-D052-4DE9-9A75-7A7ACBEBFB9F Q41771261-BF4997FB-BCD2-485D-B61C-210CA718A170 Q44046843-AF714794-12B9-477D-8F82-FCD5D408C210 Q44868340-2BDBE95C-3230-44F9-AD63-DB18F12E39CB

P2860

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

http://www.wikidata.org/entity/Q37025960

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@en

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@nl

type

label

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@en

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@nl

prefLabel

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@en

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.

@nl

P1433

Q37025960-6E40021A-69D4-40D2-A0F7-3A833A97D1E6

P1476

Q37025960-DC4733A3-6621-4800-A361-93D4DD758CE0

P2093

Q37025960-393E79C1-B47B-4754-A219-512A6A29DF1C

Q37025960-5C70B0CE-4ADA-49D7-8A0E-C3B386FA849C

Q37025960-75144F07-59CB-40E5-A565-B246726822DA

Q37025960-E8A49F7C-64EE-4C7E-9918-89037FD0C9E8

P2860

Q37025960-0EA520D0-01A7-49B0-BB15-60F552021B1F

Q37025960-1739EBD2-829F-40A7-811D-A46B7E9D03FE

Q37025960-2A7A23A2-ED98-4B07-B791-A3B542D368EA

Q37025960-2F847B9D-671D-468C-B4DE-A9DDCF1275E3

Q37025960-3A818127-4ABA-41CD-B0B0-7D20CCBDA9E5

Q37025960-3F1E75D4-E3A4-45A0-B4E7-BDC9744305EE

Q37025960-4D3BB29C-06DA-4DD5-8EAA-13DDB115128E

Q37025960-4D9966B3-663B-4D71-852F-BC18ABCDC54F

Q37025960-5C073539-38E5-4E9C-BDB0-0A0BD524879C

Q37025960-5DC4AE55-4DF6-40FA-ACD7-F14C48B11496

P304

Q37025960-C5A2C7D8-2E61-4AAA-9A26-6640A488198F

P31

Q37025960-4D37D54A-4187-4F03-A2D7-6324A569461F

P356

Q37025960-8AB94404-3135-404E-9B35-17B4A9115DEE

P433

Q37025960-385BBCAE-1D5D-4CBF-9309-E3F160A0555F

P478

Q37025960-C3175C18-99D3-44DA-AD1B-954D73583BCD

P50

Q37025960-33337366-75E7-4985-838E-668256775505

Q37025960-9C239190-8585-4027-943B-C06BCBE81B35

P577

Q37025960-BE6E5A96-E3F9-45BE-8AEB-27DBB58EE03B

P698

Q37025960-351B5028-1F91-4BBD-A819-983793187B6A

P356

14737140.7.12.1763

P1433

Expert Review of Anticancer Therapy

P1476

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients

@en

P2093

Dirk J van Veldhuisen

http://www.w3.org/2001/XMLSchema#string

Dirk T Sleijfer

http://www.w3.org/2001/XMLSchema#string

Maarten Alexander de Korte

http://www.w3.org/2001/XMLSchema#string

Patrick J Perik

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Visualization of cell death in vivo with the annexin A5 imaging protocol

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling

Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

P304

1763-1771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.7.12.1763

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jourik A Gietema

Elisabeth de Vries

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18062750

http://www.w3.org/2001/XMLSchema#string